Nystatin Cream 10000 Units
Ashlie Mealey
Nystatin is a polyene antimycotic obtained from Streptomyces noursei. It is a yellow to light tan powder with a cereal-like odor, very soluble in water, and slightly to sparingly soluble in alcohol. Structural formula:
Nystatin Cream contains the antifungal antibiotic nystatin at a concentration of 100,000 USP Nystatin Units per gram in an aqueous, perfumed cream base containing purified water, propylene glycol, methylparaben, propylparaben, white petrolatum, glyceryl monostearate, polyethylene glycol 400 monostearate, ceteareth-15, medical antifoam AF emulsion, aluminum hydroxide gel, titanium dioxide, sorbitol solution, and, if necessary, sodium hydroxide for pH adjustment.
Nystatin provides specific therapy for all localized forms of candidiasis. Symptomatic relief is rapid, often occurring within 24 to 72 hours after the initiation of treatment. Cure is effected both clinically and mycologically in most cases of localized candidiasis.
Nystatin Cream USP for topical use, contains 100,000 USP nystatin units per gram. Inactive ingredients: emulsifying wax, glycerin, isopropyl myristate, lactic acid, purified water, sodium hydroxide, and sorbic acid.
Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing levels of nystatin, Candida albicans does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of Candida(C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides) become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed.
If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other pathogens.
2. Even if symptomatic relief occurs within the first few days of treatment, the patient should be advised not to interrupt or discontinue therapy until the prescribed course of treatment is completed.
It also comes mixed with steroids, antiseptics or antibacterials as a cream or ointment. Brand names for creams and ointments containing nystatin include Trimovate, Timodine, Nystaform and Nystaform HC.
It usually takes nystatin liquid around a week to treat oral thrush, but you'll need to continue taking it for 2 days after this to make sure all the fungus has been killed. Take it for as long as your doctor advises.
If you're using cream or ointment containing nystatin mixed with other ingredients, you may only need to use it for 7 to 14 days but it will depend on your skin condition. Your doctor will tell you how long to use it for.
If you're using a cream or ointment containing nystatin, take care that your baby does not touch any areas of your body where you've used it. Wash your hands after you've used it and before picking up your baby.
If you're breastfeeding and you have thrush (candida) of the breast, you can use nystatin to treat this, although other treatments are usually more effective. Your baby will also need to be treated at the same time with their own medicine.
When using it on your breasts, wash it off your breasts or nipples, then wash your hands before feeding your baby. It's usually better to use cream rather than ointment when breastfeeding, as it's easier to wash off.
There's not enough information to say that complementary medicines, herbal remedies and supplements are safe to take with nystatin. They're not tested in the same way as pharmacy and prescription medicines. They're generally not tested for the effect they have on other medicines.
Common side effects of nystatin cream include skin irritation, itching, or redness. Tell your doctor if you have side effects such as severe burning, itching, rash, or pain where nystatin cream is applied.
Nystatin preparations should be applied liberally to affected areas twice a day or as indicated until healing is complete. Nystatin cream is usually preferred to nystatin ointment in candidiasis involving areas of the skin that may come in contact with other areas of the skin; very moist lesions are best treated with Nystatin topical powder.
It is not likely that other drugs you take orally or inject will have an effect on topically applied Nystatin Cream. But many drugs can interact with each other. Tell your doctor all prescription and over-the-counter medications and supplements you use.
Nystatin cream for topical use, contains 100,000 USP nystatin units per gram in a cream base containing aluminum hydroxide gel, ceteareth-15, glyceryl monostearate, polyethylene glycol 400 monostearate, propylene glycol, purified water, simethicone emulsion, sorbitol solution, titanium dioxide, white petrolatum, methylparaben, propylparaben, and sodium hydroxide.
If irritation or sensitization develops, treatment shouldbe discontinued and appropriate measures taken as indicated. It is recommendedthat KOH smears, cultures, or other diagnostic methods be used to confirm thediagnosis of cutaneous or mucocutaneous candidiasis and to rule out infectioncaused by other pathogens.
No long-term animal studies have been performed toevaluate the carcinogenic potential of nystatin. No studies have been performedto determine the mutagenicity of nystatin or the effects on male or female fertility.
Animal reproduction studies have not been conducted withany nystatin cream. It also is not known whether this cream can cause fetalharm when used by a pregnant woman or can affect reproductive capacity.Nystatin cream should be prescribed for a pregnant woman only if the potentialbenefit to the mother outweighs the potential risk to the fetus.
Clinical studies with nystatin cream did not includesufficient numbers of subjects aged 65 years and older to determine whetherthey respond differently than younger subjects. Other reported clinical experiencehas not identified differences in responses between elderly and youngerpatients, but greater sensitivity of some older individuals cannot be ruledout.
Nystatin is an antibiotic which is both fungistatic andfungicidal in vitro against a wide variety of yeasts and yeast-like fungi,including Candida albicans, C. parapsilosis, C. tropicalis, C.guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophytonrubrum, T. mentagrophytes. Nystatin acts by binding to sterols in the cellmembrane of susceptible species resulting in a change in membrane permeabilityand the subsequent leakage of intracellular components. On repeatedsubculturing with increasing levels of nystatin, Candida albicans doesnot develop resistance to nystatin. Generally, resistance to nystatin does notdevelop during therapy. However, other species of Candida (C. tropicalis,C. guilliermondi, C. krusei, and C. stellatoides) become quite resistant ontreatment with nystatin and simultaneously become cross resistant toamphotericin as well. This resistance is lost when the antibiotic is removed.Nystatin exhibits no appreciable activity against bacteria, protozoa, orviruses.
Clobetasol propionate is a highly active topical corticosteroid which is of particular value when used in short courses for the treatment of recalcitrant eczemas, neurodermatoses, and other conditions which do not respond satisfactorily to less active steroids.
Clobetasol/neomycin/nystatin Cream is indicated in more resistant dermatoses such as recalcitrant eczemas and psoriasis (excluding widespread plaque psoriasis) where secondary bacterial or candidal infection is present, suspected or likely to occur, as when using occlusive dressings.
Clobetasol propionate belongs to the most potent class of topical corticosteroids (Group IV) and prolonged use may result in serious undesirable effects (see section 4.4). If treatment with a local corticosteroid is clinically justified beyond 4 weeks, a less potent corticosteroid preparation should be considered. Repeated but short courses of clobetasol propionate may be used to control exacerbations (see details below).
Apply sparingly to the affected area once or twice daily until improvement occurs. As with other highly active topical steroid preparations therapy should be discontinued when control is achieved. In the more responsive conditions this may be within a few days.
In very resistant lesions, especially where there is hyperkeratosis, the anti-inflammatory effects of Clobetasol/neomycin/nystatin Cream can be enhanced, if necessary, by occluding the treatment area with polythene. Overnight occlusion only is usually adequate to bring about a satisfactory response, thereafter improvement can be usually maintained by application without occlusion.
Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient's condition being reviewed.
Clobetasol/neomycin/nystatin Cream is suitable for use in the elderly. Caution should be exercised in cases where a decrease in renal function exists and significant systemic absorption of neomycin sulfate may occur (see section 4.4). The minimum quantity should be used for the shortest duration to achieve the desired clinical benefit.
Clobetasol/neomycin/nystatin Cream is suitable for use in children (2 years and over) at the same dose as adults. A course of treatment for a child should be limited to 5 days and occlusion should not be used. It should be noted that the child's napkin may act as an occlusive dressing. A possibility of increased absorption exists in very young children; thus, this cream is not recommended for use in neonates and infants (younger than 2 years) (see sections 4.3 and 4.4).
93ddb68554